Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,728 across all filing types
Latest filing 2014-03-13 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
2013年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as "昆明制药集团股份有限公司 2013 年年度报告摘要" which translates to "Kunming Pharmaceutical Group Co., Ltd. 2013 Annual Report Summary." It contains detailed financial data for the year 2013, including total assets, net profit, cash flow, shareholder information, management discussion and analysis, segment revenue and cost breakdowns, investment and fundraising details, and subsidiary performance. The content is comprehensive and includes actual financial statements and substantive financial analysis for the full fiscal year 2013. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or summary notice. Therefore, this document fits the definition of an Annual Report (10-K) rather than a report publication announcement or any other category. FY 2013
2014-03-13 Chinese
关于承诺事项履行情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Kunming Pharmaceutical Group Co., Ltd. regarding the fulfillment status of certain commitments made by the company and its related parties. It references regulatory guidelines from the China Securities Regulatory Commission and provincial regulatory bodies concerning listed companies' commitments and their fulfillment. The content focuses on the company's self-inspection results about unfulfilled commitments and compliance with regulatory requirements. The document is relatively short (2393 characters) and serves as a formal disclosure or announcement rather than a detailed report containing financial statements or comprehensive analysis. It does not present financial results, audit opinions, or management discussions but rather compliance and commitment status disclosures. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-02-12 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Kunming Pharmaceutical Group Co., Ltd. It discusses the stock price deviation exceeding 20% over three trading days and confirms no undisclosed material information affecting stock price. It references compliance with Shanghai Stock Exchange listing rules and provides a risk warning to investors. The document is short (976 characters) and is an announcement about stock price movement and related disclosures, not a financial report or detailed analysis. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2014-02-12 Chinese
关于会计师事务所更名的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the name change of the company's auditor due to the auditor's organizational restructuring. It explicitly states that this change does not constitute a change of the auditor and no shareholder meeting or resolution is required. The document is short (754 characters) and serves as a formal notification rather than a financial report or audit report itself. It does not contain financial data, audit opinions, or detailed audit results. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2014-01-26 Chinese
2013年度业绩提示性公告
Regulatory Filings Classification · 95% confidence The document is a performance forecast announcement for the fiscal year 2013 by Kunming Pharmaceutical Group Co., Ltd. It provides estimated net profit growth and some preliminary financial data but explicitly states that the final audited financial data will be disclosed in the formal 2013 annual report. The document is short (616 characters) and serves as an earnings preview rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis, so it is not an Annual Report (10-K) or Interim Report (IR). It is also not a full Earnings Release (ER) since it is a forecast rather than actual results. Given the nature and length, this fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of expected performance without full financial data.
2014-01-09 Chinese
关于获得新版GMP证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (432 characters) about the company receiving a new GMP (Good Manufacturing Practice) certificate from the National Medical Products Administration. It is a regulatory compliance update related to quality certification, not a financial report, management change, or shareholder meeting material. It does not contain financial data or detailed report content. It is an official regulatory announcement about certification status, fitting best under Regulatory Filings (RNS).
2014-01-06 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.